Advertisement
Advertisement

ALRN

ALRN logo

Aileron Therapeutics Inc

1.86
USD
-0.06
-3.13%
Dec 18, 15:59 UTC -5
Closed
...

Aileron Therapeutics Inc Profile

About

Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers which are in clinical stage. Aileron Therapeutics, Inc. is based in Cambridge, Massachusetts.

Info & Links

CEO

Brian Windsor

Headquarters

12407 N. MOPAC EXPY., SUITE 250 #390
AUSTIN, TX 78758, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.aileronrx.com

Auditor

Marcum LLP

Share holders

467

Employees

15

Aileron Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

40.31M

Enterprise Value

22.63M

Enterprise Value/EBITDA(ttm)

-0.77

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.97

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-74.08%

Return on Invested Capital(ttm)

-150.06%

Return on Assets(ttm)

-27.93%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.30M

Net Income Available to Common(ttm)

-29.24M

Diluted EPS(ttm)

-3.12

Share Statistics

Beta (5Y Monthly)

2.22

52-Week Change

-23.14%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

21.67M

Dividend Yield

0.00%

Float4

20.56M

% Held by Insiders

5.10%

% Held by Institutions

90.89%

Balance Sheet

Total Cash(mrq)

17.68M

Total Cash Per Share(mrq)

0.82

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.30%

Quick Ratio(mrq)

3.30%

Book Value Per Share(mrq)

2.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.81

Free Cash Flow(ytd)

-17.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement